Milestone Pharmaceuticals  logo
Milestone Pharmaceuticals MIST
$ 2.0 -3.85%

Quarterly report 2025-Q2
added 08-12-2025

report update icon

Milestone Pharmaceuticals Market Cap 2011-2025 | MIST

As of October 09, 2025 Milestone Pharmaceuticals has a market cap of $ 67 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Milestone Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
52.2 M 120 M 207 M 116 M 347 M - - - - - - - -
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011360 M360 M270 M270 M180 M180 M90 M90 M00
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
347 M 52.2 M 169 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Cellectis S.A. Cellectis S.A.
CLLS
203 M $ 4.3 12.57 % $ 116 M franceFrance
Graybug Vision Graybug Vision
GRAY
1.97 M $ 0.44 -11.23 % $ 9.65 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
14.1 K $ 11.3 -10.17 % $ 12.2 K -
Galera Therapeutics Galera Therapeutics
GRTX
7.65 M $ 0.14 -32.59 % $ 7.61 M usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
6.55 M $ 2.52 -1.18 % $ 6.35 M usaUSA
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
167 M $ 4.37 -1.58 % $ 28.1 M chinaChina
Caladrius Biosciences Caladrius Biosciences
CLBS
3.58 M $ 0.43 -16.75 % $ 25.8 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
590 M $ 0.27 -29.58 % $ 126 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
253 B $ 184.71 0.49 % $ 251 B cayman-islandsCayman-islands
Midatech Pharma plc Midatech Pharma plc
MTP
79 M $ 0.29 -18.52 % $ 27.3 M britainBritain
Aeterna Zentaris Aeterna Zentaris
AEZS
41.4 M $ 5.72 5.93 % $ 314 M canadaCanada
ContraFect Corporation ContraFect Corporation
CFRX
1.08 M $ 1.47 -5.16 % $ 5.39 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
672 M $ 4.93 1.02 % $ 90.8 M britainBritain
Advaxis Advaxis
ADXS
1.87 M $ 0.31 -9.65 % $ 45.9 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
32.8 M $ 3.93 -5.76 % $ 99.8 M usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
110 M $ 6.2 - $ 154 M usaUSA
Zymeworks Zymeworks
ZYME
845 M $ 6.42 - $ 404 M canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
52.7 M $ 10.5 - $ 231 M usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
813 M $ 9.5 - $ 1.7 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
308 M $ 2.58 -4.8 % $ 255 M usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
52.7 M $ 0.56 7.23 % $ 2.72 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.72 M $ 0.5 - $ 7.46 M israelIsrael
Generation Bio Co. Generation Bio Co.
GBIO
179 M $ 6.33 1.61 % $ 408 M usaUSA
Kiromic BioPharma Kiromic BioPharma
KRBP
4.83 M $ 3.15 6.61 % $ 3.08 M usaUSA
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
6.89 B $ 179.68 - $ 10.9 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
538 M $ 44.15 -0.23 % $ 916 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
450 M $ 0.32 - $ 23.9 M usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
1.1 B $ 18.44 - $ 1.94 B canadaCanada
Kaleido Biosciences Kaleido Biosciences
KLDO
73.7 M $ 0.29 -3.69 % $ 12.4 M usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
73.7 M $ 2.19 - $ 105 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
316 M $ 1.35 2.27 % $ 206 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
40.9 M $ 6.59 2.17 % $ 53.8 M usaUSA
Humanigen Humanigen
HGEN
12.5 M $ 0.04 -81.12 % $ 4.28 M usaUSA
Aptinyx Aptinyx
APTX
9.48 M $ 0.06 -39.0 % $ 4.57 M usaUSA
Tyme Technologies Tyme Technologies
TYME
186 M $ 0.31 8.07 % $ 54 M usaUSA
Keros Therapeutics Keros Therapeutics
KROS
410 M $ 15.96 1.98 % $ 598 M usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
584 M $ 2.64 -0.75 % $ 18.7 M danmarkDanmark
Krystal Biotech Krystal Biotech
KRYS
5.02 B $ 187.18 2.27 % $ 5.35 B usaUSA
Kymera Therapeutics Kymera Therapeutics
KYMR
2.28 B $ 56.29 -1.11 % $ 4.22 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
32.8 M $ 0.39 - $ 26.5 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
41.7 M $ 0.47 - $ 12.5 M belgiumBelgium
Brickell Biotech Brickell Biotech
BBI
11.4 M $ 2.11 -5.38 % $ 6.06 M usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
72.7 M $ 0.05 -15.0 % $ 3.04 M usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
240 M $ 0.06 -55.98 % $ 2.15 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
103 M $ 8.37 - $ 401 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
19.6 M $ 3.17 1.93 % $ 17.4 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
960 M $ 0.37 -10.95 % $ 876 K usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
467 M $ 20.01 - $ 958 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
5.65 B $ 49.55 -6.81 % $ 3.04 B usaUSA
Sierra Oncology Sierra Oncology
SRRA
288 M $ 54.89 -0.05 % $ 1.34 B canadaCanada